Shares of Flexion Therapeutics soared in trading on Oct. 11 after Pacira Biosciences announced the acquisition of the Burlington, Massachusetts-based biopharmaceutical company for $427 million in cash.
Dr. Reb Close and Susan Burnell, MSN RN, CEN, share proven actionable strategies for tracking and addressing prescription opioid abuse both individually and collectively with other providers in this free webinar.
Mumbai-based Glenmark Pharmaceuticals is spinning off its innovation business into a U.S.-based standalone company.
Head and neck surgery patients in Hong Kong are far less likely to be prescribed opioids than patients undergoing similar surgeries in the U.S., new research shows.
Industry insiders say Johnson & Johnson is no longer interested in Pfizer’s $20 billion consumer healthcare business
The United States needs to curb excessive opioid prescribing and improve access to pain management techniques, suggests a new government study.